Previous 10 | Next 10 |
The U.S. government has given Johnson & Johnson (NYSE: JNJ) control of a Baltimore production facility operated by Emergent BioSolutions (NYSE: EBS) . The move is the latest development in a controversy over Emergent's production of Johnson & Johnson's coronaviru...
Emergent BioSolutions (EBS) has received a contract modification from BARDA to increase the original task order by $23M.The additional sum will be used to purchase biologics manufacturing equipment specific to Johnson & Johnson’s (JNJ) COVID-19 vaccine for the potential expansion o...
HHS has increased Emergent’s task order by $23 million to purchase additional biologics manufacturing equipment Reaffirms 2021 financial guidance GAITHERSBURG, Md., April 04, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that the Compa...
The Biden administration has put Johnson & Johnson (JNJ) in charge of the Emergent BioSolutions (EBS) beleaguered Baltimore plant that ruined 15M doses of the company's COVID-19 vaccine, according to a report in The New York Times.The newspaper says HHS made the move to avoid further foul...
An experimental COVID-19 treatment from Emergent BioSolutions (EBS) failed in a phase 3 trial.Emergent's experimental SARS-CoV-2 immunoglobulin therapy (COVID-HIG), which was combined with Gilead's (GILD) Veklury (remdesivir), did not provide any benefit when compared to standard o...
GAITHERSBURG, Md., April 02, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today provided an update on the evaluation of its investigational SARS-CoV-2 Immune Globulin Intravenous (Human) (COVID-HIG) for the treatment of hospitalized patients with COVID-19. The Phase 3 Inpa...
Emergent BioSolutions (NYSE: EBS) was a dog of a stock Thursday, plummeting to close down by over 13%. This followed news that the company apparently erred in the production process of Johnson & Johnson 's (NYSE: JNJ) recently authorized coronavirus vaccine. Johnson ...
Gainers: AeroCentury (ACY) +235%.Liberty TripAdvisor (LTRPB) +106%.Uxin (UXIN) +53%.Universe Pharmaceuticals (UPC) +36%.Applied Molecular Transport (AMTI) +31%.Euro Tech Holdings (CLWT) +26%.PLBY Group (PLBY) +25%.Nuvve (NVVE) +24%.Moxian (MOXC) +18%.Sonoma Pharmaceuticals (SNOA) +1...
Emergent BioSolutions ([[EBS]] -12.9%) is trading sharply lower today in reaction to yesterday’s New York Times report over the accidental vaccine contamination at its Baltimore plant manufacturing two coronavirus vaccines developed by Johnson & Johnson ([[JNJ]]...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Eyes on a rare payrolls dayThe tech stock rally looks to keep going with Nasdaq futures solidly higher at the open, but the broader market is more cautions...
News, Short Squeeze, Breakout and More Instantly...
Emergent Biosolutions Inc. Company Name:
EBS Stock Symbol:
NYSE Market:
Emergent Biosolutions Inc. Website:
New video and radio segments raise awareness of a potentially life-saving, three-step method that anyone can use to respond in a suspected opioid poisoning GAITHERSBURG, Md., July 24, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the launch of a new opio...
GAITHERSBURG, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 6, 2024, at 5:00 pm eastern time to discuss the financial results for the second quarter 2024, key business updates, revenue guidance for the third quarter of...
The extension to a four-year shelf-life helps improve naloxone access as communities continue to grapple with the growing opioid epidemic; product with the extended shelf life has officially begun shipping WINNIPEG, Manitoba, July 22, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolution...